Market revenue in 2022 | USD 5.6 million |
Market revenue in 2030 | USD 10.5 million |
Growth rate | 8.2% (CAGR from 2022 to 2030) |
Largest segment | Blood culture media |
Fastest growing segment | Assay Kits & Reagents |
Historical data | 2018 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Instruments, Blood Culture Media, Assay Kits & Reagents, Software |
Key market players worldwide | BD, BioMerieux SA, Thermo Fisher Scientific Inc, Danaher Corp, Roche Holding AG ADR, Luminex, Koninklijke Philips NV, Bruker Corp, Cepheid, Immunexpress |
Blood culture media was the largest segment with a revenue share of 39.29% in 2022. Horizon Databook has segmented the Argentina sepsis diagnostics market based on instruments, blood culture media, assay kits & reagents, software covering the revenue growth of each sub-segment from 2018 to 2030.
The rise in sepsis cases, partly attributed to the emergence of new bacterial strains, such as M1UK clones, has underscored the need for more sophisticated diagnostic technologies in Argentina.
According to a study published by the Pan-American Health Organization (PAHO) in November 2023, Argentina experienced a notable rise in reported cases and deaths from invasive group A streptococcal disease, linked to the emergence of M1UK clones and a sublineage of M1 with the toxin.
This increase has prompted PAHO/WHO to advise member states to enhance clinical & genomic surveillance and ensure prompt diagnosis and treatment of this severe condition. Socioeconomic factors influence health outcomes but are rarely considered in severe diseases. Sepsis is a common condition in low- and middle-income countries.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account